Pesquisa | BVS IEC

BQ.1.1, XBB.1, and XBB.1.5 neutralization after bivalent mRNA COVID-19 booster in patients with cancer.

Ehmsen, Sidse; Pedersen, Rune M; Bang, Line L; Asmussen, Anders; Kragh, Amalie; Holm, Dorte K; Sydenham, Thomas V; Jensen, Thøger G; Jeppesen, Stefan S; Frederiksen, Henrik; Andersen, Thomas E; Ditzel, Henrik J.

Cancer Cell ; 41(4): 649-650, 2023 04 10.

Artigo em Inglês | MEDLINE | ID: mdl-36804967

RESUMO

Ehmsen et al. evaluate the neutralizing capacity to current SARS-CoV-2 variants in patients with cancer before and after receiving the BNT162b2 bivalent mRNA vaccine booster. Bivalent vaccine provides some protection against BQ.1.1 but fails to protect against XBB.1 and XBB.1.5 in patients with cancer.

Assuntos

COVID-19 , Neoplasias , Humanos , COVID-19/prevenção & controle , SARS-CoV-2/genética , Vacina BNT162 , Neoplasias/genética , Neoplasias/terapia , RNA Mensageiro/genética

Increased antibody titers and reduced seronegativity following fourth mRNA COVID-19 vaccination in patients with cancer.

Ehmsen, Sidse; Asmussen, Anders; Jeppesen, Stefan S; Nilsson, Anna Christine; Kragh, Amalie; Frederiksen, Henrik; Ditzel, Henrik J.

Cancer Cell ; 40(8): 800-801, 2022 08 08.

Artigo em Inglês | MEDLINE | ID: mdl-35803259

Assuntos

COVID-19 , Neoplasias , COVID-19/prevenção & controle , Vacinas contra COVID-19 , Humanos , RNA Mensageiro , Vacinação

Antibody responses following third mRNA COVID-19 vaccination in patients with cancer and potential timing of a fourth vaccination.

Ehmsen, Sidse; Asmussen, Anders; Jeppesen, Stefan S; Nilsson, Anna Christine; Østerlev, Sabina; Kragh, Amalie; Frederiksen, Henrik; Ditzel, Henrik J.

Cancer Cell ; 40(4): 338-339, 2022 04 11.

Artigo em Inglês | MEDLINE | ID: mdl-35216675

Assuntos

COVID-19 , Neoplasias , Formação de Anticorpos , COVID-19/prevenção & controle , Vacinas contra COVID-19 , Humanos , Neoplasias/genética , RNA Mensageiro , Vacinação

RESUMO

Assuntos

Assuntos

Assuntos

ENVIAR RESULTADO:

SELEÇÃO DE REFERÊNCIAS

DETALHE DA PESQUISA